These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 29209029

  • 21. Screening of viral-vectored P. falciparum pre-erythrocytic candidate vaccine antigens using chimeric rodent parasites.
    Kolli SK, Salman AM, Ramesar J, Chevalley-Maurel S, Kroeze H, Geurten FGA, Miyazaki S, Mukhopadhyay E, Marin-Mogollon C, Franke-Fayard B, Hill AVS, Janse CJ.
    PLoS One; 2021; 16(7):e0254498. PubMed ID: 34252120
    [Abstract] [Full Text] [Related]

  • 22. In vitro and in vivo inhibition of malaria parasite infection by monoclonal antibodies against Plasmodium falciparum circumsporozoite protein (CSP).
    Livingstone MC, Bitzer AA, Giri A, Luo K, Sankhala RS, Choe M, Zou X, Dennison SM, Li Y, Washington W, Ngauy V, Tomaras GD, Joyce MG, Batchelor AH, Dutta S.
    Sci Rep; 2021 Mar 05; 11(1):5318. PubMed ID: 33674699
    [Abstract] [Full Text] [Related]

  • 23. Importance of the Immunodominant CD8+ T Cell Epitope of Plasmodium berghei Circumsporozoite Protein in Parasite- and Vaccine-Induced Protection.
    Gibbins MP, Müller K, Glover M, Liu J, Putrianti ED, Bauza K, Reyes-Sandoval A, Matuschewski K, Silvie O, Hafalla JCR.
    Infect Immun; 2020 Sep 18; 88(10):. PubMed ID: 32719159
    [Abstract] [Full Text] [Related]

  • 24. A linear peptide containing minimal T- and B-cell epitopes of Plasmodium falciparum circumsporozoite protein elicits protection against transgenic sporozoite challenge.
    Calvo-Calle JM, Oliveira GA, Watta CO, Soverow J, Parra-Lopez C, Nardin EH.
    Infect Immun; 2006 Dec 18; 74(12):6929-39. PubMed ID: 17030584
    [Abstract] [Full Text] [Related]

  • 25. Sporozoite immunization of human volunteers under chemoprophylaxis induces functional antibodies against pre-erythrocytic stages of Plasmodium falciparum.
    Behet MC, Foquet L, van Gemert GJ, Bijker EM, Meuleman P, Leroux-Roels G, Hermsen CC, Scholzen A, Sauerwein RW.
    Malar J; 2014 Apr 05; 13():136. PubMed ID: 24708526
    [Abstract] [Full Text] [Related]

  • 26. Transgenic parasites stably expressing full-length Plasmodium falciparum circumsporozoite protein as a model for vaccine down-selection in mice using sterile protection as an endpoint.
    Porter MD, Nicki J, Pool CD, DeBot M, Illam RM, Brando C, Bozick B, De La Vega P, Angra D, Spaccapelo R, Crisanti A, Murphy JR, Bennett JW, Schwenk RJ, Ockenhouse CF, Dutta S.
    Clin Vaccine Immunol; 2013 Jun 05; 20(6):803-10. PubMed ID: 23536694
    [Abstract] [Full Text] [Related]

  • 27. Protective efficacy of baculovirus dual expression system vaccine expressing Plasmodium falciparum circumsporozoite protein.
    Iyori M, Nakaya H, Inagaki K, Pichyangkul S, Yamamoto DS, Kawasaki M, Kwak K, Mizukoshi M, Goto Y, Matsuoka H, Matsumoto M, Yoshida S.
    PLoS One; 2013 Jun 05; 8(8):e70819. PubMed ID: 23951015
    [Abstract] [Full Text] [Related]

  • 28. Assessment of the Plasmodium falciparum Preerythrocytic Antigen UIS3 as a Potential Candidate for a Malaria Vaccine.
    Longley RJ, Halbroth BR, Salman AM, Ewer KJ, Hodgson SH, Janse CJ, Khan SM, Hill AVS, Spencer AJ.
    Infect Immun; 2017 Mar 05; 85(3):. PubMed ID: 28031267
    [Abstract] [Full Text] [Related]

  • 29. Cellular and humoral immune effector mechanisms required for sterile protection against sporozoite challenge induced with the novel malaria vaccine candidate CelTOS.
    Bergmann-Leitner ES, Legler PM, Savranskaya T, Ockenhouse CF, Angov E.
    Vaccine; 2011 Aug 11; 29(35):5940-9. PubMed ID: 21722682
    [Abstract] [Full Text] [Related]

  • 30. Characterization of immunoglobulin G antibodies to Plasmodium falciparum sporozoite surface antigen MB2 in malaria exposed individuals.
    Nguyen TV, Sacci JB, de la Vega P, John CC, James AA, Kang AS.
    Malar J; 2009 Oct 23; 8():235. PubMed ID: 19852802
    [Abstract] [Full Text] [Related]

  • 31. Antibodies elicited by Plasmodium falciparum circumsporozoite proteins lacking sequentially deleted C-terminal amino acids reveal mouse strain and epitopes specific differences.
    Hayashi CTH, Cao Y, Zavala F, Simonyan H, Young CN, Kumar N.
    Vaccine; 2023 Nov 02; 41(46):6824-6833. PubMed ID: 37827967
    [Abstract] [Full Text] [Related]

  • 32. A chemokine-fusion vaccine targeting immature dendritic cells elicits elevated antibody responses to malaria sporozoites in infant macaques.
    Luo K, Gordy JT, Zavala F, Markham RB.
    Sci Rep; 2021 Jan 13; 11(1):1220. PubMed ID: 33441615
    [Abstract] [Full Text] [Related]

  • 33. Malaria vaccine candidate antigen targeting the pre-erythrocytic stage of Plasmodium falciparum produced at high level in plants.
    Voepel N, Boes A, Edgue G, Beiss V, Kapelski S, Reimann A, Schillberg S, Pradel G, Fendel R, Scheuermayer M, Spiegel H, Fischer R.
    Biotechnol J; 2014 Nov 13; 9(11):1435-45. PubMed ID: 25200253
    [Abstract] [Full Text] [Related]

  • 34. The N-terminal domain of Plasmodium falciparum circumsporozoite protein represents a target of protective immunity.
    Bongfen SE, Ntsama PM, Offner S, Smith T, Felger I, Tanner M, Alonso P, Nebie I, Romero JF, Silvie O, Torgler R, Corradin G.
    Vaccine; 2009 Jan 07; 27(2):328-35. PubMed ID: 18984024
    [Abstract] [Full Text] [Related]

  • 35. Cutting edge: a new tool to evaluate human pre-erythrocytic malaria vaccines: rodent parasites bearing a hybrid Plasmodium falciparum circumsporozoite protein.
    Persson C, Oliveira GA, Sultan AA, Bhanot P, Nussenzweig V, Nardin E.
    J Immunol; 2002 Dec 15; 169(12):6681-5. PubMed ID: 12471098
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Immunization with genetically attenuated P. falciparum parasites induces long-lived antibodies that efficiently block hepatocyte invasion by sporozoites.
    Finney OC, Keitany GJ, Smithers H, Kaushansky A, Kappe S, Wang R.
    Vaccine; 2014 Apr 17; 32(19):2135-8. PubMed ID: 24582635
    [Abstract] [Full Text] [Related]

  • 38. Flow Cytometry-Based Assessment of Antibody Function Against Malaria Pre-erythrocytic Infection.
    Douglass AN, Metzger PG, Kappe SH, Kaushansky A.
    Methods Mol Biol; 2015 Apr 17; 1325():49-58. PubMed ID: 26450378
    [Abstract] [Full Text] [Related]

  • 39. Live attenuated rubella vectors expressing Plasmodium falciparum circumsporozoite protein (Pf-CSP) provide a novel malaria vaccine platform in the rhesus macaque.
    Virnik K, Zhou W, Medvedev A, Walsh G, Perry-Anderson J, Majam V, Felber BK, Kumar S, Berkower I.
    Biochem Biophys Res Commun; 2021 Nov 05; 577():58-63. PubMed ID: 34507066
    [Abstract] [Full Text] [Related]

  • 40. Vectored antibody gene delivery protects against Plasmodium falciparum sporozoite challenge in mice.
    Deal C, Balazs AB, Espinosa DA, Zavala F, Baltimore D, Ketner G.
    Proc Natl Acad Sci U S A; 2014 Aug 26; 111(34):12528-32. PubMed ID: 25114213
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.